These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31528343)

  • 21. Intra-tumour heterogeneity: a looking glass for cancer?
    Marusyk A; Almendro V; Polyak K
    Nat Rev Cancer; 2012 Apr; 12(5):323-34. PubMed ID: 22513401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Many private mutations originate from the first few divisions of a human colorectal adenoma.
    Kang H; Salomon MP; Sottoriva A; Zhao J; Toy M; Press MF; Curtis C; Marjoram P; Siegmund K; Shibata D
    J Pathol; 2015 Nov; 237(3):355-62. PubMed ID: 26119426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncogenesis by mutations in anti-oncogenes: a view.
    Den Otter W; Koten JW; Van der Vegt BJ; Beemer FA; Boxma OJ; Derkinderen DJ; De Graaf PW; Huber J; Lips CJ; Roholl PJ
    Anticancer Res; 1990; 10(2B):475-87. PubMed ID: 2190526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intra-tumour heterogeneity - going beyond genetics.
    Caiado F; Silva-Santos B; Norell H
    FEBS J; 2016 Jun; 283(12):2245-58. PubMed ID: 26945550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer heterogeneity: implications for targeted therapeutics.
    Fisher R; Pusztai L; Swanton C
    Br J Cancer; 2013 Feb; 108(3):479-85. PubMed ID: 23299535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mutator phenotype theory can explain the complex morphology and behaviour of cancers.
    Bignold LP
    Cell Mol Life Sci; 2002 Jun; 59(6):950-8. PubMed ID: 12169025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Epigenetic Perspective on Intra-Tumour Heterogeneity: Novel Insights and New Challenges from Multiple Fields.
    Beyes S; Bediaga NG; Zippo A
    Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bet hedging or not? A guide to proper classification of microbial survival strategies.
    de Jong IG; Haccou P; Kuipers OP
    Bioessays; 2011 Mar; 33(3):215-23. PubMed ID: 21254151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multi-Site Tumour Sampling Improves the Detection of Intra-Tumour Heterogeneity in Oral and Oropharyngeal Squamous Cell Carcinoma.
    Jie W; Bai J; Yan J; Chi Y; Li BB
    Front Med (Lausanne); 2021; 8():670305. PubMed ID: 34041255
    [No Abstract]   [Full Text] [Related]  

  • 30. Bet-hedging as a complex interaction among developmental instability, environmental heterogeneity, dispersal, and life-history strategy.
    Scheiner SM
    Ecol Evol; 2014 Feb; 4(4):505-15. PubMed ID: 24634734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "Bet hedging" against climate change in developing and adult animals: roles for stochastic gene expression, phenotypic plasticity, epigenetic inheritance and adaptation.
    Burggren WW; Mendez-Sanchez JF
    Front Physiol; 2023; 14():1245875. PubMed ID: 37869716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Divergent mutational processes distinguish hypoxic and normoxic tumours.
    Bhandari V; Li CH; Bristow RG; Boutros PC;
    Nat Commun; 2020 Feb; 11(1):737. PubMed ID: 32024819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Mathematical Study of the Influence of Hypoxia and Acidity on the Evolutionary Dynamics of Cancer.
    Fiandaca G; Delitala M; Lorenzi T
    Bull Math Biol; 2021 Jun; 83(7):83. PubMed ID: 34129102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intratumoural evolutionary landscape of high-risk prostate cancer: the PROGENY study of genomic and immune parameters.
    Linch M; Goh G; Hiley C; Shanmugabavan Y; McGranahan N; Rowan A; Wong YNS; King H; Furness A; Freeman A; Linares J; Akarca A; Herrero J; Rosenthal R; Harder N; Schmidt G; Wilson GA; Birkbak NJ; Mitter R; Dentro S; Cathcart P; Arya M; Johnston E; Scott R; Hung M; Emberton M; Attard G; Szallasi Z; Punwani S; Quezada SA; Marafioti T; Gerlinger M; Ahmed HU; Swanton C
    Ann Oncol; 2017 Oct; 28(10):2472-2480. PubMed ID: 28961847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Range Expansion Theories Could Shed Light on the Spatial Structure of Intra-tumour Heterogeneity.
    Gidoin C; Peischl S
    Bull Math Biol; 2019 Nov; 81(11):4761-4777. PubMed ID: 30535848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deciphering Tumour Heterogeneity: From Tissue to Liquid Biopsy.
    Gilson P; Merlin JL; Harlé A
    Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clonal relationship and alcohol consumption-associated mutational signature in synchronous hypopharyngeal tumours and oesophageal squamous cell carcinoma.
    Ko JM; Guo C; Liu C; Ning L; Dai W; Tao L; Lo AW; Wong CW; Wong IY; Chan FS; Wong CL; Chan KK; Law TT; Lee NP; Liu Z; Jiang H; Li Z; Law S; Lung ML
    Br J Cancer; 2022 Dec; 127(12):2166-2174. PubMed ID: 36261585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The evolution of resistance and tolerance as cancer defences.
    Thomas F; Giraudeau M; Gouzerh F; Boutry J; Renaud F; Pujol P; Tasiemski A; Bernex F; Maraver A; Bousquet E; Dormont L; Osterkamp J; Roche B; Hamede R; Ujvari B
    Parasitology; 2020 Mar; 147(3):255-262. PubMed ID: 31727197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stochasticity in the Genotype-Phenotype Map: Implications for the Robustness and Persistence of Bet-Hedging.
    Nichol D; Robertson-Tessi M; Jeavons P; Anderson AR
    Genetics; 2016 Dec; 204(4):1523-1539. PubMed ID: 27770034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative Clinical Imaging Methods for Monitoring Intratumoral Evolution.
    Kim JY; Gatenby RA
    Methods Mol Biol; 2017; 1513():61-81. PubMed ID: 27807831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.